AI-based Medical Diagnostic Tools MarketPosted by johnson on July 5th, 2019 The latest market report published by Credence Research, Inc. “AI-based Medical Diagnostic Tools Market By Diagnostic Tools (Medical Imaging Tools, Automated Detection Systems, Other), By Application (Eye Care, Oncology, Radiology, Cardiovascular, Pathology, Others) - Growth, Future Prospects And Competitive Landscape, 2019 – 2027” the AI-based medical diagnostic tools market expected to grow at a CAGR of 25.6% during the forecast period from 2019 to 2027. Browse the full report at https://www.credenceresearch.com/report/ai-based-medical-diagnostic-tools-market Market Insights The global AI-based medical diagnostic tools market is growing efficiently from 2019 to 2027 accredited to the rise in interest for automated and holistic diagnosis along with upgraded technology expansion in the AI industry. The medical diagnostic tools/devices provides advice on patient’s health, and physical activity along with top applications including digital imaging, cloud-based platform for interaction, automated diagnosis and predictive analytics. Top corporations are distinguishing its AI-based solutions into actionable health diagnostics. The personalized medical technology companies in the U.S., France, Japan, Israel and U.K are gaining traction in the diagnostics industry, and additionally, they instruct and manage patient big data for future diagnostics. Moreover, rising incidences of chronic disorders along with wide applications of AI-based medical diagnostic tools in diabetes, oncology, cardiology diseases, eye care, infections and other complications will drive the growth of the market during the forecast period. Top companies are mainly focusing on FDA approval for AI-based devices. The growing number of partnerships with research centers and association by key AI workstations & laboratories globally will boost the active demand in the near future. For instance, in November 2018, ScreenPoint Medical received clearance from the U.S. FDA for Transpara detection and decision support software, innovated to assist radiologists with the reading of screening mammograms. Moreover, in April 2018, Viz.ai received FDA clearance for automated computed tomography perfusion software. However, burden of chronic disorders, less awareness related to AI usage in hospitals, high cost of services & administration and patient data security along with fewer diagnostic options are few factors restraining the overall growth of the AI-based medical diagnostic tools market on a global scale. Key Market Movements:
Market Segmentation Diagnostic Tools (2017–2027; US$ Mn)
Application Segment (2017–2027; US$ Mn)
Geography Segment (2017–2027; US$ Mn)
Like it? Share it!More by this author |